top of page

 PARTNERS 

EVI recognises the power of collaboration and engages with partners worldwide to harness the best knowledge and expertise from leaders in the field of vaccine research and development (R&D). 

OUR PARTNERS
Global network for worldwide impact

arrow&v
Abbott

The Netherlands

Projects:

FLUCOP

Abbott

Areas:

Cross-cutting

Artemis Bio-Support B.V.

The Netherlands

Projects:

FLUCOP

Artemis Bio-Support B.V.

Areas:

Cross-cutting

AstraZeneca AB

Sweden

Projects:

FLUCOP

AstraZeneca AB

Areas:

Cross-cutting

Austrian Agency for Health and Food Safety Ltd. (AGES)

Austria

Projects:

VAC2VAC

Austrian Agency for Health and Food Safety Ltd. (AGES)

Areas:

Cross-cutting

BIOASTER - Fondation de Cooperation Scientifique

France

Projects:

TRANSVAC2, TRANSVAC-DS

BIOASTER - Fondation de Cooperation Scientifique

Areas:

Cross-cutting

Batavia Biosciences B.V.

The Netherlands

Projects:

CEPI-Nipah

Batavia Biosciences B.V.

Areas:

Nipah virus disease

Bavaria Nordic

Denmark

Projects:

VAC2VAC

Bavaria Nordic

Areas:

Cross-cutting

Beijing Science and Technology Linkedin CO LTD, S&T

China

Projects:

SENET

Beijing Science and Technology Linkedin CO LTD, S&T

Areas:

Cross-cutting

Beijing University of Chinese Medicine (BUCM)

China

Projects:

SENET

Beijing University of Chinese Medicine (BUCM)

Areas:

Cross-cutting

Biomedical Primate Research Centre (BPRC)

The Netherlands

Projects:

TRANSVAC2, TRANSVAC-DS, VAC2VAC, FLUCOP

Biomedical Primate Research Centre (BPRC)

Areas:

Cross-cutting

Contact us

We'd love to hear from you!

For the latest updates follow EVI on:

  • LinkedIn
  • Twitter
  • YouTube
bottom of page